Goldman Sachs
DARE icon

Goldman Sachs’s Dare Bioscience DARE Stock Holding History

Goldman Sachs’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,551
Closed -$493K – 6618
2021
Q4 		$493K Sell
20,551
-723
-3% -$14.9K ﹤0.01% 5400
2021
Q3 		$426K Buy
21,274
+19,807
+1,350% +$390K ﹤0.01% 5294
2021
Q2 		$33K Sell
1,467
-579
-28% -$9.9K ﹤0.01% 6114
2021
Q1 		$41K Sell
2,046
-7,618
-79% -$186K ﹤0.01% 5963
2020
Q4 		$155K Buy
+9,664
New +$135K ﹤0.01% 5174
2018
Q1 		– Sell
-956
Closed -$25K – 5972
2017
Q4 		$25K Sell
956
-210
-18% -$6.75K ﹤0.01% 6080
2017
Q3 		$44K Buy
+1,166
New +$57.2K ﹤0.01% 6280
2017
Q1 		– Sell
-282
Closed -$24K – 6795
2016
Q4 		$24K Buy
+282
New +$26.9K ﹤0.01% 6597
2016
Q2 		– Sell
-139
Closed -$45K – 7048
2016
Q1 		$45K Buy
139
+32
+30% +$9.02K ﹤0.01% 6479
2015
Q4 		$36K Sell
107
-2
-2% -$830 ﹤0.01% 6682
2015
Q3 		$48K Sell
109
-191
-64% -$96K ﹤0.01% 6804
2015
Q2 		$166K Sell
300
-136
-31% -$93.4K ﹤0.01% 6287
2015
Q1 		$471K Buy
436
+66
+18% +$63.9K ﹤0.01% 5194
2014
Q4 		$276K Hold
370
– – ﹤0.01% 5866
2014
Q3 		$187K Sell
370
-30
-8% -$16K ﹤0.01% 6216
2014
Q2 		$278K Buy
+400
New +$309K ﹤0.01% 5921

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Goldman Sachs's DARE Position: Q1 2022 in Review

Goldman Sachs sold out of Dare Bioscience (DARE) in Q1 2022, closing a stake of 20,551 shares — an estimated $493K sold.

Goldman Sachs first reported a position in DARE in Q2 2014 and held it in 16 quarters. The position peaked at $493K in Q4 2021. 40 funds tracked by Wall St. Rank hold DARE as of Q1 2022.

  • Goldman Sachs reported no remaining Dare Bioscience position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 20,551 Dare Bioscience shares in Q1 2022, an estimated $493K.
  • Goldman Sachs first reported a position in Dare Bioscience in Q2 2014 and held it in 16 quarters.
  • Goldman Sachs's Dare Bioscience position peaked at $493K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.